Site Map Contact Us Home

Clinical Trials

While The Kelly Heinz-Grundner Brain Tumor Foundation (KHG) is primarily focused on brain tumor awareness and education with a goal of early detection, it also understands the importance of clinical research. Specifically, KHG knows that research is the long-term key to success. The truth is that there will never be a cure without research.

Sadly, there just isn’t enough funding to support all of the promising advances being made everyday by the many world-class institutions (hospitals, medical schools, etc.). What’s more, patient participation in clinical trials is also insufficient, potentially resulting in severe delays in the availability of new treatments.

KHG would like to help resolve this problem by providing this dedicated clinical trials webpage. Here readers can learn more about the “ins and outs” of clinical trials and also access online information regarding the “latest and greatest” clinical trials for brain tumors.

What are clinical trials?
New treatments and therapies for treating diseases are discovered in the laboratory by “basic” scientists. Our understanding of potential promising therapies is refined in extensive pre-clinical tests. Before being made generally available to patients on the open-market as prescription medication or treatments they are tested in clinical trials. A clinical trial (also called medical research, clinical research or a clinical study) is a research study designed by scientists and medical experts who invite people to participate by testing the new therapy or treatment to help answer questions about the potential new treatment. The purpose of a clinical trial is to test the safety and efficacy of new treatments. Clinical trials are an essential and necessary component of the scientific research process. Put simply, without clinical trials no new medications or treatments will become available.

Clinical trials conducted in the U.S. are regulated by the U.S. Food and Drug Administration (FDA), and overseen on multiple levels by medical experts and committees comprised of physicians, scientists, and patient and community representatives whose role is to protect patients from unnecessary risk. Clinical trials are conducted and carefully monitored in a series of phases. Each phase being refined to test the safety, tolerability, and effectiveness of the potential treatment.

Why do brain tumor clinical research studies need volunteers?
Over the past decade, the National Institutes of Health (NIH) have devoted significant federal dollars to making substantial scientific discoveries and advances in the neurosciences. This investment has resulted in a recent explosion of new research insights about diseases of the brain, including brain tumors.

However, a potential crisis in brain tumor clinical research is looming: the number of people volunteering to participate in brain tumor clinical trials is not keeping up with the growth in available trials. This means that some trials are being unnecessarily delayed because of difficulties in finding patients who are willing to participate.

That’s why brain tumor advocacy groups have decided to initiate a community-wide effort to educate and inform people with brain tumors, their families and caregivers about clinical trials, and to increase the number of people with brain tumors who are willing to learn about the studies and consider participation. The goal of the campaign is to bring scientists, medical researchers and study participants together to help make new treatments available, more quickly, to the people who need them.

What questions should I consider before joining a clinical trial?
Before participating in a clinical trial, you should confer with to your neuro-oncologist, family and friends. Make a list of any questions or concerns that develop in these conversations, and take these to the study coordinator to get an answer before you sign-up. Below is a list of suggested questions that will help you understand more about the trial you are considering:

  1. What information is available about the treatment from pre-clinical studies?
  2. What are the known side effects and what is the risk of new side effects emerging?
  3. Will I have to stop taking my current medications and/or nutritional supplements?
  4. How will the study staff work with my primary physician and/or neuro-oncologist to keep him or her informed about my care?
  5. How much time do I need to commit?
  6. Will I have to travel?

How do I find out about available clinical trials?
Researching clinical trials can be quite challenging. Finding the right clinical trial for you requires even more time and more patience. With that said, the following list provides some good places to start. Of course, you should also ask your neuro-oncologist about the trials that he or she may know about, as well. In addition, you can also contact major research centers in your area, such as hospitals, universities and clinical research centers.

www.virtualtrials.org
This website is dedicated to brain tumor clinical trials and lists trials presently seeking patients. You can search by trial type or location and review each trial's eligibility criteria. You can also sign up to receive regular updates in print or e-mail bulletins about future trials.

www.emergingmed.com
Since December 2000, EmergingMed has guided more than 115,000 patients through a search for cancer clinical trials. EmergingMed’s Navigator service enables you to create a detailed profile to see if you match the eligibility requirements of more than 10,000 trials in the United States and Canada.

www.cancer.gov/clinicaltrials
Here you'll find information about federal and industry-sponsored clinical trials. In addition, you'll find a useful glossary of clinical research terms, clinical trial results and other trial-related educational materials. This information can also be accessed through the NCI’s Information Service Center by calling 1-800-4-CANCER.

Note: The information on this webpage is provided "as is" for general information only. KHG does not offer medical advice or recommendations and individuals should not rely on the information posted this page as a substitute for consultations with qualified health care professionals who are familiar with individual medical conditions and needs. KHG strongly recommends that care and treatment decisions related to brain tumors and any other medical condition be made in consultation with a patient's physician or other qualified health care professionals who are familiar with the individual's specific health situation.

back to top
Privacy   Terms   Contact Us